Education
About Us
Working with TipRanks
Follow Us
Eastwood Bio-Medical Canada Inc (TSE:EBM)
:EBM
EBM Stock Chart & Stats
C$0.74
>-C$0.01(-1.00%)
At close: 4:00 PM EST
C$0.74
>-C$0.01(-1.00%)
Day’s Range― - ―
52-Week RangeC$0.30 - C$1.10
Previous CloseN/A
Volume2.20K
Average Volume (3M)3.49K
Market Cap
C$50.98M
Enterprise ValueC$29.67M
Total Cash (Recent Filing)C$22.03K
Total Debt (Recent Filing)C$71.33K
Price to Earnings (P/E)―
Beta-0.86
Next Earnings
Mar 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding68,885,970
10 Day Avg. Volume3,055
30 Day Avg. Volume3,488
Financial Highlights & Ratios
PEG Ratio9.00
Price to Book (P/B)-52.06
Price to Sales (P/S)96.16
P/FCF Ratio-4.44K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EBM FAQ
What was Eastwood Bio-Medical Canada Inc’s price range in the past 12 months?
Eastwood Bio-Medical Canada Inc lowest stock price was C$0.29 and its highest was C$1.10 in the past 12 months.
What is Eastwood Bio-Medical Canada Inc’s market cap?
Eastwood Bio-Medical Canada Inc’s market cap is C$50.98M.
When is Eastwood Bio-Medical Canada Inc’s upcoming earnings report date?
Eastwood Bio-Medical Canada Inc’s upcoming earnings report date is Mar 02, 2026 which is in 63 days.
How were Eastwood Bio-Medical Canada Inc’s earnings last quarter?
Eastwood Bio-Medical Canada Inc released its earnings results on Sep 25, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Eastwood Bio-Medical Canada Inc overvalued?
According to Wall Street analysts Eastwood Bio-Medical Canada Inc’s price is currently Overvalued.
Does Eastwood Bio-Medical Canada Inc pay dividends?
Eastwood Bio-Medical Canada Inc does not currently pay dividends.
What is Eastwood Bio-Medical Canada Inc’s EPS estimate?
Eastwood Bio-Medical Canada Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eastwood Bio-Medical Canada Inc have?
Eastwood Bio-Medical Canada Inc has 68,885,970 shares outstanding.
What happened to Eastwood Bio-Medical Canada Inc’s price movement after its last earnings report?
Eastwood Bio-Medical Canada Inc reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Eastwood Bio-Medical Canada Inc?
Currently, no hedge funds are holding shares in TSE:EBM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada.
Technical Analysis
Arch Biopartners
―
Diagnos
―
Willow Biosciences Inc
―
ZYUS Life Sciences
―
Sona Nanotech Inc
―